Reduced-Dose Craniospinal Irradiation for Central Nervous System-Relapsed Neuroblastoma

類似資料

• Combination of Bevacizumab, Irinotecan and Temozolomide for Refractory or Relapsed Neuroblastoma: Results of a Phase II Study
  著者:: Modak, Shakeel, 等
  出版事項: (2017)
• Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
  著者:: Kushner, Brian H., 等
  出版事項: (2009)
• Reduced-dose Radiation Therapy to the Primary Site is Effective for High-risk Neuroblastoma: Results from a Prospective Trial
  著者:: Casey, Dana L., 等
  出版事項: (2019)
• HYPERFRACTIONATED LOW-DOSE (21 Gy) RADIOTHERAPY FOR CRANIAL SKELETAL METASTASES IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA
  著者:: Kushner, Brian H., 等
  出版事項: (2009)
• Dose-Escalation is Needed for Gross Disease in High-Risk Neuroblastoma
  著者:: Casey, Dana L., 等
  出版事項: (2018)